News outlets report on the arrival of an experimental Ebola drug in Liberia and discuss how the limited doses of the drug will be allocated.

Associated Press/New York Times: Liberia Gets Ebola Drug; Ponders Who Should Get It
“Liberian officials faced an excruciating choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful. ZMapp, the untested Ebola drug, arrived in the West African country late Wednesday. Assistant Health Minister Tolbert Nyenswah said three or four people would begin getting it Thursday. The government had previously said two doctors would receive the treatment, but it was unclear who else would…” (8/14).

Reuters: Consignment of experimental Ebola drug arrives in Liberia
“A consignment of experimental Ebola drugs arrived by plane in Liberia on Wednesday to treat two doctors suffering from the virus, which has killed more than 1,000 people across four West African countries…” (MacDougall, 8/14).